Review
Open access
Aug 2026
Liquid Biopsy for Molecular Residual Disease Detection and Postoperative Surveillance in Gastric Cancer: Current Evidence and Future Directions
The biological basis of molecular residual disease, liquid biopsy technologies, ctDNA data, the concept of molecular recurrence, and the future prospects of multi-analytic and artificial intelligence (AI)-assisted surveillance models in gastric cancer are summarized.
L. Lazaridou, Kalliopi Vakalou, A. Dimaki et al.
· International Journal of Mol... · 0 citations